XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.1
EQUITY-BASED COMPENSATION - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Jul. 19, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares outstanding 1,603,972 338,233 1,563,972 166,233  
Number of stock options granted (shares) 40,000 182,000      
Fair value $ 0.1 $ 0.1      
Unrecognized compensation cost, options $ 1.3 $ 0.5      
Unrecognized compensation cost, recognition period 2 years 10 months 24 days        
Flex Pharma          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares outstanding 34,385       90,279
Employee stock option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options, contractual term 10 years        
Minimum | Employee stock option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period 1 year        
Maximum | Employee stock option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period 4 years        
2015 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares remaining available for grant of stock awards (shares) 1,020,690